The legislation is a central condition of the NDP’s political pact with the governing Liberals, and includes a program to cover select contraceptive and diabetes medications and supplies.
A U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer.